Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
07/2012
07/19/2012US20120183537 1,2,4-thiazoloidin-3-one derivatives and their use in the treatment of cancer
07/19/2012US20120183536 Methods of using corticotropin-releasing factor for the treatment of cancer
07/19/2012US20120183535 use of inhibitors of bruton's tyrosine kinase (btk)
07/19/2012US20120183534 Methods, compositions and apparatuses for facilitating regeneration
07/19/2012US20120183533 Mimotopes of hiv env
07/19/2012US20120183532 Compounds stimulating undesirable cellular adhesion and applications thereof
07/19/2012US20120183531 Methods for Inhibiting Yellow Color Formation in a Composition
07/19/2012US20120183530 Stabilized immune modulatory rna (simra) compounds
07/19/2012US20120183529 Compositions and methods of use for therapeutic antibodies
07/19/2012US20120183528 Pnmt as a novel marker for progenitor cells
07/19/2012US20120183527 Measurement of anti-amyloid antibodies in human blood
07/19/2012US20120183498 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
07/19/2012US20120183495 Avian colony stimulating factor 1 receptor binding proteins
07/19/2012US20120183472 Immunotherapy of b-cell malignancies using anti-cd22 antibodies
07/19/2012US20120183471 Specific binding proteins and uses thereof
07/19/2012CA2824438A1 Use of toll-like receptor agonist for treating cancer
07/19/2012CA2824417A1 Pharmaceutical composition for treating cancer
07/19/2012CA2824389A1 Antibodies directed against influenza
07/19/2012CA2824313A1 Tlr3 binding agents
07/19/2012CA2824143A1 Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
07/19/2012CA2824060A1 Anti-tlr4 antibodies and methods of use thereof
07/19/2012CA2823913A1 Stem cell factor inhibitor
07/19/2012CA2821117A1 Combination therapy including tumor associated antigen binding antibodies
07/18/2012EP2476706A2 Anti-MN antibodies and methods of using same
07/18/2012EP2476705A1 Monoclonal antibodies against NKG2A
07/18/2012EP2476704A2 Humanized monoclonal antibodies to heptocyte growth factor
07/18/2012EP2476702A1 Monoclonal antibodies against the pbp2-a protein and homologous sequences for the treatment of infections by and immunodiagnostics of bacteria of the firmicutes phylum
07/18/2012EP2476699A2 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
07/18/2012EP2476698A2 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
07/18/2012EP2476697A2 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
07/18/2012EP2476695A2 Peptide vaccines for cancers expressing tumor-associated antigens
07/18/2012EP2476694A2 Peptide vaccines for cancers expressing tumor-associated antigens
07/18/2012EP2476693A2 Peptide vaccines for cancers expressing tumor-associated antigens
07/18/2012EP2476692A2 Peptide vaccines for cancers expressing tumor-associated antigens
07/18/2012EP2476438A1 Medicament including antibody composition specifically bound to human cc chemokine receptor 4 (ccr4)
07/18/2012EP2476437A2 Immunogenic peptides and their use in immune disorders
07/18/2012EP2476436A2 Immunogenic peptides and their use in immune disorders
07/18/2012EP2476435A2 Immunogenic peptides and their use in immune disorders
07/18/2012EP2476434A1 Immunogenic composition
07/18/2012EP2476433A1 Immunogenic composition
07/18/2012EP2476432A1 Compositions that include hemagglutinin, methods of making and methods of use thereof
07/18/2012EP2476431A1 Lyophilised antigen composition
07/18/2012EP2476427A2 A method of treating cancer comprising a VEGF-B antagonist
07/18/2012EP2475995A1 S. aureus allergen
07/18/2012EP2475397A1 Use of interleukin-1 beta mutein conjugates in the treatment of diabetes
07/18/2012EP2475393A2 Formulation for room temperature stabilization of a live attenuated bacterial vaccine
07/18/2012EP2475391A1 Extracellular targeted drug conjugates
07/18/2012EP2475390A1 Methods and compositions for the treatment of receptor tyrosine kinase mediated diseases or disorders
07/18/2012EP2475389A1 Use of an anti-il6 antibody to decrease hepcidin in cancer patients
07/18/2012EP2475388A1 Use of il-33 antagonists to treat fibrotic disease
07/18/2012EP2475387A1 Use of vap-1 inhibitors for treating fibrotic conditions
07/18/2012EP2475386A1 Hypoallergenic hybrid polypeptides for the treatment of allergy
07/18/2012EP2475385A1 Combination vaccines against respiratory tract diseases
07/18/2012EP2475384A1 New vaccine formulations comprising saponin-containing adjuvants
07/18/2012EP2475383A1 Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof
07/18/2012EP2475382A2 Method of treating eosinophilic esophagitis
07/18/2012EP2475377A2 Novel bacteriophage and antibacterial composition comprising the same
07/18/2012EP2475370A1 Screening method and therapy with agonists of ddah i
07/18/2012EP2399993A9 Hypo-immunogenic streptavidin and use thereof
07/18/2012EP2175881B1 Intradermal influenza vaccine
07/18/2012EP2086576B1 H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
07/18/2012EP1982190B1 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
07/18/2012EP1959990B1 PQS and its conjugates as adjuvants and their uses in pharmaceutical compositions
07/18/2012EP1930414B1 Method for activation treatment of antigen-presenting cell
07/18/2012EP1893649B1 Method for the potentiation of opioid analgesics effects on pain
07/18/2012EP1881838B1 Antitumor agent on the base of bcg vaccine, method for its preparation and its use
07/18/2012EP1871416B1 Methods for treating osteoarthitis pain by administering a nerve growth factor antagonist and compositions containing the same
07/18/2012EP1869086B1 Methods and compositions for modulating and detecting wisp activity
07/18/2012EP1711528B1 Treatment of cancer with novel anti-il 13 monoclonal antibodies
07/18/2012EP1437961B1 Methods of suppressing microglial activation
07/18/2012EP1432735B1 Antagonistic anti-htnfsf13b human antibodies
07/18/2012CN1935260B Human antibodies that bind human tnfalpha
07/18/2012CN1723041B Stable immunogenic product comprising antigenic heterocomplexes
07/18/2012CN1449445B Ev-vegf nucleic acids and polypeptides and methods of use
07/18/2012CN102597262A Producing an immune response for reducing the risk of developing brucellosis
07/18/2012CN102597234A Humanized anti-amyloid-beta oligomer antibody
07/18/2012CN102597233A Humanized anti-amyloid-beta oligomer antibody
07/18/2012CN102597005A Bispecific antibodies that bind to complement proteins
07/18/2012CN102597003A Compositions and methods for treating inflammatory disorders
07/18/2012CN102596999A Antibody recognizing turn structure in amyloid beta
07/18/2012CN102596997A Antibodies that specifically bind to A beta oligomers and use thereof
07/18/2012CN102596996A Antibody having activity of inhibiting infection with hepatitis c virus (hcv) and use of same
07/18/2012CN102596993A Multimeric peptide conjugates and uses thereof
07/18/2012CN102596250A Methods for treating irritable bowel syndrome (IBS)
07/18/2012CN102596249A AX1 and AX189 PCSK9 antagonists and variants
07/18/2012CN102596248A Antibody therapeutics with local activity in the digestive tract
07/18/2012CN102596247A Novel proteins
07/18/2012CN102596246A Methods for diagnosing diabetes and determining effectiveness of treatments
07/18/2012CN102596245A Combination therapy of an afucosylated CD20 antibody with bendamustine
07/18/2012CN102596244A 丙型肝炎病毒疫苗组合物 HCV vaccine composition
07/18/2012CN102596243A Nanoemulsion vaccines
07/18/2012CN102596242A Actinobacillus suis antigens
07/18/2012CN102596241A Means and methods for producing artificial capsular polysaccharides of neisseria meningitidis
07/18/2012CN102596240A Hybrid polypeptides including meningococcal fHBP sequences
07/18/2012CN102596239A Immunogenic composition comprising antigenic S. aureus proteins
07/18/2012CN102596238A Apparatus and method for cryogranulating a pharmaceutical composition
07/18/2012CN102596237A Method of treating eosinophilic esophagitis
07/18/2012CN102596236A Antigenic Tau peptides and uses thereof
07/18/2012CN102596235A Compositions and methods of use of immunotoxins comprising ranpirnase (RAP) show potent cytotoxic activity
07/18/2012CN102596234A Dendritic cell vaccines for asparaginyl-beta-hydroxylase expressing tumors
1 ... 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 ... 1823